Cargando…

Serum Tenascin-C and Alarin Levels Are Associated with Cardiovascular Diseases in Type 2 Diabetes Mellitus

BACKGROUND: Tenascin-C (TNC), an extracellular matrix glycoprotein, is elevated in inflammatory and cardiovascular pathologies, whereas alarin, a novel orexigenic peptide, participates in insulin resistance and glycometabolism. The roles of these molecules in individuals with cardiovascular disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mingming, Wu, Mengjiao, Zhu, Hua, Hua, Yulin, Ma, Zijun, Yao, Jiayi, Feng, Bin, Shi, Bimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050282/ https://www.ncbi.nlm.nih.gov/pubmed/35493201 http://dx.doi.org/10.1155/2022/2009724

Ejemplares similares

Plasma and aqueous levels of alarin and adipsin ın patients with and without diabetic retinopathy
por: Gül, Fatih Cem, et al.
Publicado: (2022)

Distribution of Alarin Immunoreactivity in the Mouse Brain
por: Eberhard, Nicole, et al.
Publicado: (2011)

Intracerebroventricular Injection of Alarin Increased Glucose Uptake in Skeletal Muscle of Diabetic Rats
por: Zhang, Zhenwen, et al.
Publicado: (2015)

Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients
por: Zhou, Xin, et al.
Publicado: (2021)

Thermoregulatory effect of alarin, a new member of the galanin peptide family
por: Mikó, Alexandra, et al.
Publicado: (2014)

Regulatory effects and potential therapeutic implications of alarin in depression, and arguments on its receptor
por: Abebe, Endeshaw Chekol, et al.
Publicado: (2022)

A paradoxical role for alarin in the nervous control of energy homeostasis and thermoregulation: orexigenic but hypermetabolic
por: Roth, Joachim
Publicado: (2014)

Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats
por: Li, Jinshuang, et al.
Publicado: (2021)

The evolving roles of alarin in physiological and disease conditions, and its future potential clinical implications
por: Abebe, Endeshaw Chekol, et al.
Publicado: (2022)

Decreased serum C1Q/TNF-related protein 4 concentrations are associated with type 2 diabetes mellitus
por: Liu, Zheng, et al.
Publicado: (2021)

Circulating alarin concentrations are high in patients with type 2 diabetes and increased by glucagon-like peptide-1 receptor agonist treatment: An Consort-compliant study
por: Hu, Wenjing, et al.
Publicado: (2019)

Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system
por: Imanaka-Yoshida, Kyoko, et al.
Publicado: (2014)

Tenascin C in radiation‐induced lung damage: Pathological expression and serum level elevation
por: Toyomasu, Yutaka, et al.
Publicado: (2022)

Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes
por: Feng, Bin, et al.
Publicado: (2020)

Tenascin-C: an emerging prognostic biomarker in diabetes
por: Yonebayashi, Saori, et al.
Publicado: (2020)

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
Publicado: (1994)

Clinical significance and prognosis of serum tenascin-C in patients with sepsis
por: Yuan, Weifang, et al.
Publicado: (2018)

Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome
por: Vasanthi, Murugaiyan, et al.
Publicado: (2020)

Tenascin-C serum levels and its prognostic power in non-small cell lung cancer
por: Gebauer, Florian, et al.
Publicado: (2016)

Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes Mellitus
por: Guo, Yuting, et al.
Publicado: (2022)

Invasion of Melanoma in Double Knockout Mice Lacking Tenascin‐X and Tenascin‐C
por: Matsumoto, Ken‐ichi, et al.
Publicado: (2002)

Advances in tenascin-C biology
por: Midwood, Kim S., et al.
Publicado: (2011)

Tenascin-C and integrins in cancer
por: Yoshida, Toshimichi, et al.
Publicado: (2015)

Immunosuppression via Tenascin-C
por: Bellone, Matteo, et al.
Publicado: (2015)

Tenascin C in Lung Diseases
por: Donovan, Chantal, et al.
Publicado: (2023)

Exploring the Potential Link between Acute Central Serous Chorioretinopathy and Trimethylamine N-Oxide, Phoenixin, Spexin, and Alarin Molecules
por: Kaya, Mehmet Kaan, et al.
Publicado: (2023)

Tenascin-C: Friend or Foe in Lung Aging?
por: Gremlich, Sandrine, et al.
Publicado: (2021)

Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma
por: Yang, Zhao-Ting, et al.
Publicado: (2016)

The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases
por: Matsumoto, Ken-ichi, et al.
Publicado: (2020)

Tenascin-C Suppresses Rho Activation
por: Wenk, Melissa B., et al.
Publicado: (2000)

Tenascin-C: Form versus function
por: Giblin, Sean P, et al.
Publicado: (2014)

Tenascin-C in Osteoarthritis and Rheumatoid Arthritis
por: Hasegawa, Masahiro, et al.
Publicado: (2020)

Serendipity; Close Encounter of Tenascin C
por: Sakakura, Teruyo
Publicado: (2021)

Advances on the roles of tenascin-C in cancer
por: Yilmaz, Alev, et al.
Publicado: (2022)

Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E
por: Yasuda, Mina, et al.
Publicado: (2018)

Marfan syndrome with type 2 diabetes mellitus: A case report from China
por: Zhou, Yingyi, et al.
Publicado: (2019)

Tenascin turns on the EGFR
por: Jegalian, Karin
Publicado: (2001)

The evolution of tenascins and fibronectin
por: Adams, Josephine C, et al.
Publicado: (2015)

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
por: Brellier, Florence, et al.
Publicado: (2012)

Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy?
por: Kotby, Alyaa A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_21smakospnov4m803eu5unfveq